AstraZeneca News — every source, one live feed

Track AstraZeneca news in real time — Anglo-Swedish pharmaceutical company with major oncology, cardiovascular, and rare disease franchises.. fllwup^ collects the latest AstraZeneca headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.

Latest AstraZeneca headlines

  • AstraZeneca fends off lawsuit over alleged Soliris drug monopoly — Reuters
  • AstraZeneca, Alexion’s myasthenia gravis treatment enters crowded market — Endpoints News
  • Rhythm Pharma: Is AstraZeneca/Eli Lilly's Bidding War For Real? Don't Rule It Out (RYTM) — Seeking Alpha
  • AstraZeneca’s sonesitatug vedotin BLA accepted for priority review — The Pharma Letter
  • AstraZeneca Bet $2 Billion on Summit’s Cancer Drug. The FDA Just Said Not Yet. — Barron's
  • With Klygefa approvals, AZ expands myasthenia gravis domain beyond Soliris, Ultomiris — Fierce Pharma
  • Tempus AI and AstraZeneca Extend Strategic Services Agreement — TipRanks
  • AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy — Reuters
  • AstraZeneca Cuts 600 US Sales Staff as Savings Drive Kicks In — Bloomberg
  • AstraZeneca buys partner Omniose for bacterial vaccine technology — Fierce Biotech

Follow AstraZeneca live on fllwup^ · Follow in any RSS reader — or browse all topics.

Also tracking

More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.